How I use AI to turn failed drugs into new medicines

Layla Hosseini-Gerami draws on her background in chemistry and bioinformatics to help identify failed drugs and fix issues around their toxicity. Credit: Ignota Labs Ignota Labs, a company based in Cambridge, UK, uses artificial-intelligence technology to determine why drugs have failed in clinical trials, before re-engineering the most promising therapies to give them another shot at making it to the patients who need them. …